Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01289639 · ClinicalTrials.gov registry record · NA
Insulin Resistance in Non-alcoholic Fatty Liver Disease
A NA study, sponsored by VA Office of Research and Development.
- Terminated
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT01289639: Clinical Trial NA study, sponsored by VA Office of Research and Development.
NCT01289639 is a NA study that was terminated before completion, run by VA Office of Research and Development. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01289639, a NA study, was terminated before completion, sponsored by VA Office of Research and Development.
- TERMINATED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
The study is designed to investigate the relationship between insulin resistance and non-alcoholic fatty liver disease (NAFLD) and to investigate potential mechanisms underlying insulin resistance in NAFLD by determining associations between hepatic and peripheral insulin sensitivity, hepatic steatosis, dyslipidemia, inflammatory cytokines, glucose metabolism, beta-cell function and body fat distribution.
Interventions
- DRUG placebo
- DRUG pioglitazone
- DRUG fenofibrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2005-10 |
| Est. Completion | 2014-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01289639
The ClinicalTrials.gov registry entry for NCT01289639 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT01289639 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01289639 about?
NCT01289639 is a clinical study titled "Insulin Resistance in Non-alcoholic Fatty Liver Disease". The study is designed to investigate the relationship between insulin resistance and non-alcoholic fatty liver disease (NAFLD) and to investigate potential mechanisms underlying insulin resistance in NAFLD by determining associations between hepatic and peripheral insulin sensitivity, hepatic steato...
What is the current status of trial NCT01289639?
This trial is currently terminated. It is a NA study. The enrollment target is 11 participants. The study started on 2005-10. Estimated completion is 2014-08.
What interventions are being tested in trial NCT01289639?
The interventions under investigation include: placebo (DRUG), pioglitazone (DRUG), fenofibrate (DRUG).
Who is sponsoring clinical trial NCT01289639?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.